DAWN vs. AVDL, DVAX, PCRX, MORF, AKRO, ANIP, KNSA, GMTX, LGND, and GYRE
Should you be buying Day One Biopharmaceuticals stock or one of its competitors? The main competitors of Day One Biopharmaceuticals include Avadel Pharmaceuticals (AVDL), Dynavax Technologies (DVAX), Pacira BioSciences (PCRX), Morphic (MORF), Akero Therapeutics (AKRO), ANI Pharmaceuticals (ANIP), Kiniksa Pharmaceuticals (KNSA), Gemini Therapeutics (GMTX), Ligand Pharmaceuticals (LGND), and Gyre Therapeutics (GYRE). These companies are all part of the "pharmaceutical preparations" industry.
Avadel Pharmaceuticals (NASDAQ:AVDL) and Day One Biopharmaceuticals (NASDAQ:DAWN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings.
In the previous week, Avadel Pharmaceuticals had 11 more articles in the media than Day One Biopharmaceuticals. MarketBeat recorded 24 mentions for Avadel Pharmaceuticals and 13 mentions for Day One Biopharmaceuticals. Day One Biopharmaceuticals' average media sentiment score of 0.55 beat Avadel Pharmaceuticals' score of -0.09 indicating that Avadel Pharmaceuticals is being referred to more favorably in the media.
Avadel Pharmaceuticals has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. Comparatively, Day One Biopharmaceuticals has a beta of -1.44, suggesting that its stock price is 244% less volatile than the S&P 500.
69.2% of Avadel Pharmaceuticals shares are owned by institutional investors. Comparatively, 88.0% of Day One Biopharmaceuticals shares are owned by institutional investors. 4.0% of Avadel Pharmaceuticals shares are owned by insiders. Comparatively, 8.4% of Day One Biopharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Avadel Pharmaceuticals currently has a consensus price target of $24.17, suggesting a potential upside of 56.01%. Day One Biopharmaceuticals has a consensus price target of $37.67, suggesting a potential upside of 132.94%. Given Avadel Pharmaceuticals' higher probable upside, analysts clearly believe Day One Biopharmaceuticals is more favorable than Avadel Pharmaceuticals.
Avadel Pharmaceuticals has higher revenue and earnings than Day One Biopharmaceuticals. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than Day One Biopharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Day One Biopharmaceuticals has a net margin of 0.00% compared to Day One Biopharmaceuticals' net margin of -284.42%. Avadel Pharmaceuticals' return on equity of -57.28% beat Day One Biopharmaceuticals' return on equity.
Avadel Pharmaceuticals received 298 more outperform votes than Day One Biopharmaceuticals when rated by MarketBeat users. Likewise, 65.22% of users gave Avadel Pharmaceuticals an outperform vote while only 58.18% of users gave Day One Biopharmaceuticals an outperform vote.
Summary
Avadel Pharmaceuticals beats Day One Biopharmaceuticals on 9 of the 16 factors compared between the two stocks.
Get Day One Biopharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DAWN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Day One Biopharmaceuticals Competitors List
Related Companies and Tools